FBT Holdings — First Trust NYSE Arca Biotechnology Index Fund
All 32 reported holdings of First Trust NYSE Arca Biotechnology Index Fund (FBT) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Moderna Inc | 5.26% | $119.45M |
| United Therapeutics Corporation | 4.36% | $98.94M |
| Alkermes PLC | 4.24% | $96.15M |
| Gilead Sciences Inc. | 4.09% | $92.82M |
| Axsome Therapeutics Inc. | 3.89% | $88.21M |
| Amgen Inc. | 3.83% | $87.01M |
| Corcept Therapeutics Inc. | 3.82% | $86.69M |
| Krystal Biotech Inc | 3.51% | $79.69M |
| Biogen Inc | 3.47% | $78.80M |
| Exelixis, Inc. | 3.46% | $78.54M |
| Neurocrine Biosciences Inc | 3.45% | $78.24M |
| Regeneron Pharmaceuticals, Inc. | 3.45% | $78.23M |
| Vertex Pharmaceuticals Incorporated | 3.42% | $77.62M |
| Biomarin Pharmaceutical Inc. | 3.40% | $77.28M |
| Argenx SE | 3.29% | $74.72M |
| Sarepta Therapeutics Inc | 3.24% | $73.64M |
| Halozyme Therapeutics Inc | 3.17% | $71.92M |
| BioNTech SE | 3.16% | $71.79M |
| Incyte Corporation. | 3.13% | $71.03M |
| Beone Medicines Ltd. | 3.12% | $70.88M |
| Illumina Inc | 3.10% | $70.47M |
| Natera, Inc. | 3.03% | $68.84M |
| Acadia Pharmaceuticals Inc | 2.95% | $67.04M |
| Alnylam Pharmaceuticals Inc. | 2.95% | $67.00M |
| Bio-Techne Corp | 2.83% | $64.15M |
| Genmab As | 2.78% | $63.16M |
| Veracyte Inc | 2.72% | $61.79M |
| Repligen Corporation | 2.51% | $56.96M |
| Bruker Corporation | 2.36% | $53.49M |
| Neogenomics Inc | 2.00% | $45.47M |
| Dreyfus Government Cash Management Funds | 0.06% | $1.41M |
| Daiwa Capital Markets America Inc. | 0.01% | $188.49K |